Charles River Laboratories CRL Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Business | ||||||
| DSA | $2.41B+0.2% | $2.4B-0.5% | $2.41B-0.6% | $2.43B-0.4% | $2.44B-0.5% | |
| Manufacturing | $778.46M+1.6% | $766.41M+0.2% | $764.96M-0.8% | $771.14M+1.1% | $762.62M-0.9% | |
| RMS | $841.38M-0.6% | $846.08M+0.2% | $844.08M+1.9% | $828.43M+0.8% | $821.54M-0.9% | |
| Total Revenue by Geography | ||||||
| Asia Pacific | $218.56M+6.6% | $205.02M+0.6% | $203.89M+3.4% | $197.24M+2.1% | $193.12M-1.9% | |
| Canada | $485.24M-3.2% | $501.03M+0.8% | $497.11M-2.0% | $507.39M+2.1% | $497.05M+3.1% | |
| Europe | $1.12B+1.3% | $1.1B+1.5% | $1.09B+1.0% | $1.08B+1.0% | $1.07B-1.2% | |
| Other | $57.59M-11.2% | $64.87M-0.5% | $65.2M+17.7% | $55.38M+5.0% | $52.74M-0.2% | |
| U.S. | $2.15B+0.3% | $2.14B-1.4% | $2.17B-1.0% | $2.19B-1.0% | $2.21B-1.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Charles River Laboratories break its business down?
- Charles River Laboratories (CRL) reports total revenue by business across 3 parts — DSA, Manufacturing and RMS. Each is extracted from the segment footnotes and tracked over time.
- Where does Charles River Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Charles River Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
